Melanoma biomarkers: current status and vision for the future. (Q37357928)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19107110%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

review article

1 reference

title

Melanoma biomarkers: current status and vision for the future (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19107110%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19107110%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Rhoda M Alani

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19107110%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Eliz Konat

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19107110%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

1 reference

23 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19107110%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Oncology

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19107110%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19107110%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19107110%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

105-117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19107110%20AND%20SRC:MED&resulttype=core&format=json

Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1296

Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1296

Microtubule-associated protein 2, a marker of neuronal differentiation, induces mitotic defects, inhibits growth of melanoma cells, and predicts metastatic potential of cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1296

Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1296

Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1296

Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin

21 January 2018

1 reference

12 December 2020

Differential expression of growth arrest, DNA damage genes and tumour suppressor gene p53 in naevi and malignant melanomas

1 reference

12 December 2020

Metallothionein - overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients

1 reference

12 December 2020

Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma

1 reference

12 December 2020

Immunohistochemical expression of nm23 in primary invasive malignant melanoma is predictive of survival outcome

1 reference

12 December 2020

Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma.

1 reference

12 December 2020

High CD44 surface expression on primary tumours of malignant melanoma correlates with increased metastatic risk and reduced survival

1 reference

12 December 2020

Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma

1 reference

12 December 2020

MART-1 is required for the function of the melanosomal matrix protein PMEL17/GP100 and the maturation of melanosomes

1 reference

12 December 2020

Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.

1 reference

12 December 2020

Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma

1 reference

12 December 2020

Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship

1 reference

12 December 2020

Tyrosinase RT-PCR as a supplement to histology for detecting melanoma and nevus cells in paraffin sections of sentinel lymph nodes.

1 reference

12 December 2020

Measurement of c-myc oncogene expression provides an accurate prognostic marker for acral lentiginous melanoma

1 reference

12 December 2020

Prognostic value of pololike kinase expression in melanomas

1 reference

12 December 2020

Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma

1 reference

12 December 2020

The developmentally regulated neural crest-associated glycotope HNK-1 predicts metastasis in cutaneous malignant melanoma

1 reference

12 December 2020

Distinct sets of genetic alterations in melanoma

1 reference

12 December 2020

Activation of c-jun N-terminal kinase is associated with cell proliferation and shorter relapse-free period in superficial spreading malignant melanoma.

1 reference

12 December 2020

Prognostic immunohistochemical markers of primary human melanomas

1 reference

12 December 2020

Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma

1 reference

12 December 2020

EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast

1 reference

12 December 2020

Lethal "thin" malignant melanoma. Identifying patients at risk

1 reference

12 December 2020

Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma

1 reference

12 December 2020

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system

1 reference

12 December 2020

Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases

1 reference

12 December 2020

Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma

1 reference

12 December 2020

Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth

1 reference

12 December 2020

PUMA expression is significantly reduced in human cutaneous melanomas

1 reference

12 December 2020

Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome

1 reference

12 December 2020

Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients

1 reference

12 December 2020

Development of a tissue array for primary melanoma with long-term follow-up: discovering melanoma cell adhesion molecule as an important prognostic marker

1 reference

12 December 2020

Sentinel lymph node evaluation in melanoma

1 reference

12 December 2020

E2F-1 induces melanoma cell apoptosis via PUMA up-regulation and Bax translocation.

1 reference

12 December 2020

Molecular prognostic markers in intermediate-thickness cutaneous malignant melanoma

1 reference

12 December 2020

The clinical significance of c-myc oncogene expression in melanomas of the scalp.

1 reference

12 December 2020

Clinical relevance of molecular staging for melanoma: comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma

1 reference

12 December 2020

Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin

1 reference

12 December 2020

Melastatin expression and prognosis in cutaneous malignant melanoma

1 reference

12 December 2020

The role of sentinel lymph node biopsy in the management of melanoma

1 reference

12 December 2020

Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma

1 reference

12 December 2020

1 reference

12 December 2020

Mitotic cyclins and cyclin-dependent kinases in melanocytic lesions

1 reference

12 December 2020

Molecular diagnostics in melanoma.

1 reference

12 December 2020

Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction--staged sentinel lymph nodes from melanoma patients.

1 reference

12 December 2020

Novel biomarkers in malignant melanoma

1 reference

12 December 2020

Prognostic value of Ki-67 expression in localized cutaneous malignant melanoma

1 reference

12 December 2020

Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000.

1 reference

12 December 2020

Pathogenetic and clinical implications of non-immunoglobulin ; BCL6 translocations in B-cell non-Hodgkin's lymphoma

1 reference

12 December 2020

Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma

1 reference

12 December 2020

Lymph node micrometastases of cutaneous melanoma: increased sensitivity of molecular diagnosis in comparison to immunohistochemistry

1 reference

12 December 2020

CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease

1 reference

12 December 2020

Patterns of melastatin mRNA expression in melanocytic tumors

1 reference

12 December 2020

Micropthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma

1 reference

12 December 2020

Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma

1 reference

12 December 2020

Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome

1 reference

12 December 2020

PAS-positive loops and networks as a prognostic indicator in cutaneous malignant melanoma

1 reference

12 December 2020

The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase

1 reference

12 December 2020

Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma.

1 reference

12 December 2020

Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma

1 reference

12 December 2020

Increased chromosome 20 copy number detected by fluorescence in situ hybridization (FISH) in malignant melanoma

1 reference

12 December 2020

Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes

1 reference

12 December 2020

FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients

1 reference

12 December 2020

Loss of beta-catenin expression associated with disease progression in malignant melanoma

1 reference

12 December 2020

Ki-67, Bcl-2 and p53 expression in primary and metastatic melanoma.

1 reference

12 December 2020

Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients.

1 reference

12 December 2020

Expression of CXCR4 Predicts Poor Prognosis in Patients with Malignant Melanoma

1 reference

12 December 2020

A cell surface marker for neural crest and placodal cells: further evolution in peripheral and central nervous system

1 reference

12 December 2020

GADD153 is an independent prognostic factor in melanoma: immunohistochemical and molecular genetic analysis

1 reference

12 December 2020

Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study.

1 reference

12 December 2020

Molecular staging of malignant melanoma: correlation with clinical outcome

1 reference

12 December 2020

Chromogenic in situ hybridization analysis of melastatin mRNA expression in melanomas from American Joint Committee on Cancer stage I and II patients with recurrent melanoma

1 reference

12 December 2020

p21(WAF1/CIP1) expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival

1 reference

12 December 2020

Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes

1 reference

12 December 2020

Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma

1 reference

12 December 2020

Significance of cell kinetic parameters in the prognosis of malignant melanoma: a review

1 reference

12 December 2020

Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients

1 reference

12 December 2020

E-cadherin expression in human melanoma

1 reference

12 December 2020